| (Values in U.S. Thousands) | Dec, 2025 | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 |
| Sales | 502,730 | 393,410 | 324,240 | 252,480 | 203,000 |
| Sales Growth | +27.79% | +21.33% | +28.42% | +24.37% | unch |
| Net Income | -60,610 | -64,660 | -83,070 | 150 | -10,930 |
| Net Income Growth | +6.26% | +22.16% | -55,479.63% | +101.37% | -2,384.10% |
Starling Oncology Institute Inc (STLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Starling Oncology Inc. is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. Starling Oncology Inc., formerly known as The Oncology Institute Inc., is based in CERRITOS, Calif.
Fiscal Year End Date: 12/31